ИШЕМИК ИНСУЛЬТ ЎТКАЗГАН БЕМОРЛАРДА ИККИ ЁҚЛАМА АНТИАГРЕГАНТ ТЕРАПИЯ ВА МОНО АНТИАГРЕГАНТ ТЕРАПИЯНИНГ ҚИЁСИЙ САМАРАДОРЛИГИ
##article.subject##:
ишемик инсульт, икки ёқлама антиагрегант терапия, моно антиагрегант терапия, яхши прогноз, ёмон прогноз##article.abstract##
Ушбу мақола 60 та биринчи марта ишемик инсульт ўтказган беморларда икки ёқлама антиагрегант терапия ва моно антиагрегант терапиянинг қиёсий самарадорлигини баҳолаш натижаларини ёритади.
Библиографические ссылки
Musaev, S., Musaeva, Y., & Rakhimbaeva, G. (2024). Neuroinflammatory mechanisms in hemorrhagic stroke: focus on the background. Journal of education and scientific medicine, 1(2), 49-58.
Rakhimbaeva GS, Abdurakhmonova KBK. ICAM-1 and CRP as biomarkers of 3-month outcome in acute ischaemic stroke. BMJ Neurol Open. 2023 Dec 20;5(2):e000516. doi: 10.1136/bmjno-2023-000516. PMID: 38145240; PMCID: PMC10749038.
Brown DL, Levine DA, Albright K, Kapral MK, Leung LY, Reeves MJ, et al. Benefits and Risks of Dual Versus Single Antiplatelet Therapy for Secondary Stroke Prevention. Stroke 2021; 52: e468-e479.
Del Giovane C, Boncoraglio GB, Bertù L, Banzi R, Tramacere I. Antiplatelet drugs for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis. BMC Neurol 2021; 21: 1-10.
Dong J, Wang F, Sundararajan S. Use of Dual Antiplatelet Therapy following Ischemic Stroke. Stroke 2020; 51: e78-e80.
Edward CJ. Ischemic stroke [Internet]. Medical Crossfire. 2022 [cited 2023 May26. Available from: https://emedicine. medscape.com/article/1916852-overview
Franziska H, Fred R. Management of Acute Ischemic Stroke. Concise Defin Rev 2020; 48: 1654-1663.
Jourdi G, Godier A, Lordkipanidzé M, Marquis-Gravel G, Gaussem P. Antiplatelet Therapy for Atherothrombotic Disease in 2022—From Population to Patient-Centered Approaches. Front Cardiovasc Med 2022; 9: 1-19.
Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, et al. 2021 Guideline for the prevention of stroke in patients with stroke and transient ischemic attack; A guideline from the American Heart Association/American Stroke Association. Stroke 2021; 52: e364–e467.
Minhas JS, Chithiramohan T, Wang X, Barnes SC, Clough RH, Kadicheeni M, et al. Oral antiplatelet therapy for acute ischaemic stroke (Review). Cochrane Database Syst Rev 2022; 1: 1–16.
Pace WD, Earl A, Bryant C. Antiplatelet Therapy for Secondary Prevention of Ischemic Stroke. Cardiovascular 2020; 45: HS8-HS12.
Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2019; 50: e344–e418.
Stahmeyer JT, Stubenrauch S, Geyer S, Weissenborn K, Eberhard S. The Frequency and Timing of Recurrent Stroke. Dtsch Arztebl Int 2019; 116: 711-717.
Tadi Prasanna FL. Acute Stroke. [Updated 2023 Feb 28]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan [Internet]. 2023 [cited 2023 May 26]. p. 88-100.
Yiping C, Neil W, Yu G, Iain T, Christiana K, Ling Y, et al. Mortality and recurrent vascular events after first incident stroke: a 9-year community-based study of 0·5 million Chinese adults. Lancet Glob Heal 2020; 8: e580-e590.
Abdurakhmonova K.B., PhD researcher
E-mail: doctorabdurakhmonova@gmail.com
Tel.: mobile: + 998 97 357-99-00
